Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
The ins and outs, and ups and downs, of occupational asthma
The ins and outs, and ups and downs, of occupational asthma

Occupational health expert David McBride discusses the agents behind occupational asthma, including isocyanates used in the construction and painting industries
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Figley KD, Elrod RH. Endemic asthma due to castor bean dust. JAMA 1928;90(2):79–82.
2. Glass WI, Power P, Burt R, et al. Work-related respiratory symptoms and lung function in New Zealand mussel openers. Am J Ind Med 1998;34(2):163–68.
3. Neitzel JJ. Enzyme catalysis: The serine proteases. Nature Education 2010;3(9):21.
4. Pawlak M, Pobłocki K, Drzeżdżon J, et al. Isocyanates and isocyanides – life-threatening toxins or essential compounds? Sci Total Environ 2024;934:173250.
5. Redlich CA, Karol MH. Diisocyanate asthma: clinical aspects and immunopathogenesis. Int Immunopharmacol 2002;2(2-3):213–24.
6. Sabbioni G, Pugh SA. New method to biomonitor workers exposed to 1,6-hexamethylene diisocyanate. Chem Res Toxicol 2022;35(12):2285–95.
7. WorkSafe. Isocyanates WES Proposal to change. 7 May 2024.
8. New Zealand Paint Manufacturers Association Incorporated. Isocyanates. 2024.